Dr. Judith Currier, chief of the division of infectious diseases in the David Geffen School of Medicine at UCLA, has been named chair of the National Institutes of Health-funded AIDS Clinical Trials Group, the largest clinical trials network focused on HIV.
Currier has been involved in clinical research studies focused on improving the treatment of HIV infection and she is the principal investigator for the UCLA AIDS prevention and treatment clinical trials unit. Her areas of research include understanding the pathogenesis and management of long term complications of HIV disease, specifically cardiovascular and metabolic complications associated with HIV treatment.
Established in 1987, the ACTG’s aim is to reduce illnesses related to HIV infection, and conducts clinical trials to find new treatments and a cure for HIV infection. Researchers with the group also study Tuberculosis, viral hepatitis and HIV-related inflammation. The group now has more than 60 sites in 12 countries. UCLA has been a site since the network’s inception.
Prior to her current position, Currier has been vice chair of the ACTG since 2010.
